Department of Chemistry, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, United States.
Anal Chem. 2012 Jun 5;84(11):4677-86. doi: 10.1021/ac202000v. Epub 2012 May 7.
Current strategies for identification and quantification of 3-nitrotyrosine (3NT) post-translationally modified proteins (PTM) generally rely on biotin/avidin enrichment. Quantitative approaches have been demonstrated which employ isotopic labeling or isobaric tagging in order to quantify differences in the relative abundances of 3NT-modified proteins in two or potentially eight samples, respectively. Here, we present a novel strategy which uses combined precursor isotopic labeling and isobaric tagging (cPILOT) to increase the multiplexing capability of quantifying 3NT-modified proteins to 12 or 16 samples using commercially available tandem mass tags (TMT) or isobaric tags for relative and absolute quantification (iTRAQ), respectively. This strategy employs "light" and "heavy" labeled acetyl groups to block both N-termini and lysine residues of tryptic peptides. Next, 3NT is reduced to 3-aminotyrosine (3AT) using sodium dithionite followed by derivatization of light and heavy labeled 3AT-peptides with either TMT or iTRAQ multiplex reagents. We demonstrate the proof-of-principle utility of cPILOT with in vitro nitrated bovine serum albumin (BSA) and mouse splenic proteins using TMT(0), TMT(6), and iTRAQ(8) reagents and discuss limitations of the strategy.
目前,鉴定和定量 3-硝基酪氨酸(3NT)翻译后修饰蛋白质(PTM)的策略通常依赖于生物素/亲和素富集。已经证明了定量方法,分别使用同位素标记或等重标记来定量两个或最多八个样本中 3NT 修饰蛋白的相对丰度差异。在这里,我们提出了一种新的策略,该策略使用组合前体同位素标记和等重标记(cPILOT),使用商业上可用的串联质量标签(TMT)或相对和绝对定量的等重标签(iTRAQ),将定量 3NT 修饰蛋白的多重化能力分别提高到 12 或 16 个样本。该策略使用“轻”和“重”标记的乙酰基来阻断胰蛋白酶肽的 N 末端和赖氨酸残基。接下来,使用连二亚硫酸钠将 3NT 还原为 3-氨基酪氨酸(3AT),然后用 TMT 或 iTRAQ 多重试剂对轻标记和重标记的 3AT-肽进行衍生化。我们使用 TMT(0)、TMT(6)和 iTRAQ(8)试剂,用体外硝化牛血清白蛋白(BSA)和小鼠脾蛋白验证了 cPILOT 的原理验证实用性,并讨论了该策略的局限性。